1. Home
  2. Services
  3. Immunoprofiling

Immunoprofiling

Explore the Complexities of the Immune System with Creative Diagnostics

Understanding the immune system's intricate landscape is fundamental for immunology research, diagnostics, and therapeutic development. Immunoprofiling is a crucial analytical tool that enables researchers to dissect immune responses across various disease contexts, including cancer, autoimmune disorders, infectious diseases, and vaccine development. At Creative Diagnostics, we offer state-of-the-art immunoprofiling services powered by advanced Protein Array (Protein Biochip) Technology, allowing precise, high-throughput detection and quantification of immune markers in a single experiment.

Understanding Protein Array Technology for Immunoprofiling

What is Protein Array Technology?

Protein arrays, also known as protein biochips, are miniaturized, high-density platforms that allow simultaneous detection and quantification of multiple proteins, such as cytokines, immune checkpoint molecules, and cellular surface markers. These biochips function similarly to DNA microarrays but are designed specifically for protein-protein interactions, immune response analysis, and biomarker discovery.

How Does Protein Array Work in Immunoprofiling?

  1. Surface Immobilization: Specific capture antibodies or recombinant proteins are immobilized on a solid support (e.g., glass slide, membrane, or silicon chip) in a defined pattern.
  2. Sample Application: The sample, which may include serum, plasma, cell lysates, or culture supernatants, is incubated on the array.
  3. Binding and Detection: Target immune markers bind to their corresponding capture molecules, followed by detection using fluorescence, chemiluminescence, or enzymatic reactions.
  4. Data Analysis: High-resolution imaging and computational algorithms quantify the bound proteins, generating a comprehensive immune response profile.

Figure 1. Reproducibility of antiviral antibody profiling using protein arrays. (Source: Bian X, et al. 2016)Figure 1. Reproducibility of antiviral antibody profiling using protein arrays. (Source: Bian X, et al. 2016)

Advantages of Protein Array Technology in Immunoprofiling

Protein array technology offers a powerful approach for immunoprofiling by enabling the simultaneous detection and quantification of dozens to hundreds of immune markers in a single experiment. Utilizing advanced laser confocal imaging and near-infrared fluorescence labeling, it achieves exceptionally high sensitivity and specificity, with picomolar detection limits. This technology requires only minimal sample volumes compared to traditional methods like ELISA or Western blot, making it highly efficient for immune analysis. Additionally, its high-throughput screening capability allows for rapid and large-scale experimentation, significantly reducing both time and costs. Furthermore, protein arrays can be customized to target specific immune markers, ensuring adaptability to diverse research needs.

Our Immunoprofiling Services

Creative Diagnostics offers a full spectrum of immunoprofiling services, utilizing cutting-edge Protein Biochip technology to provide reliable and comprehensive immune analysis. Our services include:

  1. Cytokine Profiling
    Cytokines are key regulators of immune responses, inflammation, and disease progression. Our platform enables simultaneous quantification of multiple cytokines, providing insights into immune activation, suppression, and dysregulation.
  2. T-Cell and B-Cell Profiling
    T and B lymphocytes play pivotal roles in adaptive immunity. We analyze their functional status by assessing surface markers, cytokine secretion, and activation states to evaluate immune competency.
  3. Immune Checkpoint Molecule Detection
    Immune checkpoints such as PD-1, PD-L1, CTLA-4, and others regulate immune responses and are critical targets in immunotherapy. Our platform enables precise detection of these molecules, supporting cancer immunotherapy research and drug development.
  4. Immune Escape Mechanism Analysis
    Tumors and pathogens often evade immune detection through various mechanisms. Our Protein Biochip technology helps identify immune evasion pathways, aiding in the development of novel therapeutic strategies.

Applications of Immunoprofiling with Protein Biochips

Cancer Research & Immunotherapy

  • Characterize immune responses within the tumor microenvironment.
  • Evaluate immune checkpoint inhibitor efficacy.
  • Investigate tumor immune escape mechanisms.

Vaccine Development

  • Monitor immune responses to vaccine candidates.
  • Assess T-cell and B-cell activity post-vaccination.
  • Identify protective immune signatures.

Infectious Disease Research

  • Study host-pathogen interactions and immune suppression mechanisms.
  • Investigate cytokine storms in viral infections.
  • Develop targeted immunotherapies for infectious diseases.

Autoimmune Disease Research

  • Profile dysregulated immune responses in diseases like rheumatoid arthritis, lupus, and multiple sclerosis.
  • Discover novel biomarkers for disease progression and therapeutic targets.

Why Choose Creative Diagnostics?

At Creative Diagnostics, we are dedicated to providing high-quality immunoprofiling solutions with industry-leading Protein Biochip Technology.

  • Ultra-High Sensitivity: Advanced imaging techniques enable precise detection of immune markers.
  • Comprehensive Multi-Parameter Analysis: Gain a holistic view of immune responses.
  • Rapid & Cost-Effective Solutions: High-throughput analysis reduces time and costs.
  • Customized Solutions: Tailored array designs to meet diverse research needs.

Start Your Immunoprofiling Research Today!

Creative Diagnostics is your trusted partner in immunoprofiling research. Our advanced Protein Biochip technology provides efficient, precise, and reliable immune analysis to accelerate your discoveries. Contact us today to learn how we can support your immunological studies!

Reference

  1. Bian X, Wallstrom G, Davis A, et al. Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays. Diabetes. 2016;65(1):285-296.
Online Inquiry
Services